scholarly article | Q13442814 |
P2093 | author name string | Hou-De Zhang | |
Yong-Jian Ma | |||
Ling-Ling Kang | |||
P2860 | cites work | Abnormal endogenous carbon monoxide production in children with ineffective erythropoiesis | Q68231763 |
Quantitative fractionation of serum bilirubin species by reversed-phase high-performance liquid chromatography | Q69620789 | ||
Influence of sex and sex steroids on bilirubin uridine diphosphate-glucuronosyltransferase activity of rat liver | Q70484657 | ||
Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). A study of 42 families | Q72299842 | ||
Gilbert's syndrome as a predisposing factor for idiopathic cholelithiasis in children | Q79157156 | ||
Coinheritance of Gilbert syndrome-associated UGT1A1 mutation increases gallstone risk in cystic fibrosis | Q82931817 | ||
Gilbert syndrome as a predisposing factor for cholelithiasis risk in the Greek adult population | Q83524552 | ||
Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome | Q85849012 | ||
Gallstone disease in Swedish twins is associated with the Gilbert variant of UGT1A1 | Q86445800 | ||
UGT1A1 polymorphism as a prognostic indicator of stage I ovarian clear cell carcinoma patients treated with irinotecan | Q89224292 | ||
Incidence and Risk of Gallstone Disease in Gilbert's Syndrome Patients in Indian Population | Q90622858 | ||
Inherited disorders of bilirubin metabolism | Q28217356 | ||
Gilbert's syndrome in patients with gallbladder stones | Q33474324 | ||
Antioxidant defenses and lipid peroxidation in human blood plasma | Q33688237 | ||
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome | Q34057969 | ||
Endogenous carbon monoxide production in patients with hemolytic anemia | Q34081083 | ||
Carbon Monoxide Production Associated with Ineffective Erythropoiesis* | Q34089291 | ||
Constitutional hepatic dysfunction (Gilbert's disease): its natural history and related syndromes. | Q34245707 | ||
Role of bilirubin overproduction in revealing Gilbert's syndrome: is dyserythropoiesis an important factor? | Q34474884 | ||
Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. | Q34568821 | ||
Gilbert's syndrome and the risk of death: a population-based cohort study | Q34652167 | ||
Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes | Q37378223 | ||
UGT1A1 polymorphisms in cancer: impact on irinotecan treatment | Q37682812 | ||
UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice. | Q38393997 | ||
Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases | Q38424367 | ||
Total serum bilirubin and 8-year incident type 2 diabetes mellitus: The Korean Genome and Epidemiology Study. | Q38609605 | ||
Gilbert syndrome acts as a risk factor of developing gallstone among β hemoglobinopathy Tunisian patients | Q38939002 | ||
Mortality outcomes after busulfan-containing conditioning treatment and haemopoietic cell transplantation in patients with Gilbert's syndrome: a retrospective cohort study | Q39101901 | ||
Oncology Drug Dosing in Gilbert Syndrome Associated with UGT1A1: A Summary of the Literature | Q39298701 | ||
Red blood cell survival and hyperbilirubinaemia in the Gilbert's syndrome | Q39386067 | ||
Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia | Q39400720 | ||
Endogenous Carbon Monoxide Production | Q39986159 | ||
Gilbert syndrome redefined: a complex genetic haplotype influences the regulation of glucuronidation | Q42722612 | ||
A simple carbon monoxide breath test to estimate erythrocyte turnover | Q43581081 | ||
Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection | Q46835713 | ||
Relationship between UGT1A1*27 and UGT1A1*7 polymorphisms and irinotecan-related toxicities in patients with lung cancer. | Q47604049 | ||
Human erythrocyte lifespan measured by Levitt's CO breath test with newly developed automatic instrument | Q48106155 | ||
Diagnostic criteria and contributors to Gilbert's syndrome. | Q49483894 | ||
Bilirubin dependence on UGT1A1 polymorphisms, hemoglobin, fasting time and body mass index. | Q50529323 | ||
Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival. | Q50582702 | ||
Evidence for higher red blood cell mass in persons with unconjugated hyperbilirubinemia and Gilbert's syndrome. | Q50659182 | ||
[Study on the mechanisms of diarrhea induced by a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats]. | Q52208205 | ||
Detection of Gilbert's syndrome in patients with hemolysis. A method using radioactive chromium. | Q52967041 | ||
Serum Bilirubin and Risk of Respiratory Disease and Death | Q56946006 | ||
Loci From a Genome-Wide Analysis of Bilirubin Levels Are Associated With Gallstone Risk and Composition | Q57429608 | ||
P433 | issue | 7 | |
P304 | page(s) | e19109 | |
P577 | publication date | 2020-02-01 | |
P1433 | published in | Medicine | Q15716652 |
P1476 | title | Carbon monoxide breath test assessment of mild hemolysis in Gilbert's syndrome | |
P478 | volume | 99 |
Search more.